• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.

作者信息

Stewart H J, Forrest A P, Gunn J M, Hamilton T, Langlands A O, McFadyen I J, Roberts M M

出版信息

Eur J Cancer (1965). 1980;Suppl 1:83-8.

PMID:7032945
Abstract
摘要

相似文献

1
The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
Eur J Cancer (1965). 1980;Suppl 1:83-8.
2
The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.
Clin Oncol. 1979 Sep;5(3):251-6.
3
Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
Eur J Cancer (1965). 1980;Suppl 1:107-10.
4
CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
Eur J Cancer (1965). 1980;Suppl 1:119-23.
5
Adjuvant endocrine therapy of primary operable breast cancer. Report on the Copenhagen breast cancer trials.原发性可手术乳腺癌的辅助内分泌治疗。哥本哈根乳腺癌试验报告。
Eur J Cancer (1965). 1980;Suppl 1:183-7.
6
Tamoxifen and fluoxymesterone in advanced breast cancer: a controlled clinical trial.他莫昔芬与氟羟甲睾酮治疗晚期乳腺癌：一项对照临床试验。
Cancer Treat Rep. 1980 Jan;64(1):117-21.
7
Preliminary report of a controlled trial in advanced breast cancer comparing tamoxifen with conventional hormone therapy.一项比较他莫昔芬与传统激素疗法治疗晚期乳腺癌的对照试验的初步报告。
Cancer Treat Rep. 1976 Oct;60(10):1461-2.
8
DES versus tamoxifen in advanced breast cancer.多西他赛与他莫昔芬治疗晚期乳腺癌的对比
N Engl J Med. 1981 Apr 23;304(17):1041-3. doi: 10.1056/NEJM198104233041714.
9
Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.氨鲁米特与他莫昔芬治疗转移性乳腺癌的随机试验。
Cancer Res. 1982 Aug;42(8 Suppl):3434s-3436s.
10
[Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].[通过性激素结合球蛋白结合能力变化研究人乳腺癌激素治疗的机制与分类]
Gan No Rinsho. 1984 Dec;30(15):1879-82.

引用本文的文献

1
Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer.雌激素治疗诱导未折叠蛋白反应以驱动 ER+ 乳腺癌细胞死亡。
Mol Oncol. 2019 Aug;13(8):1778-1794. doi: 10.1002/1878-0261.12528. Epub 2019 Jul 9.
2
Estrogen as therapy for breast cancer.雌激素作为乳腺癌的治疗方法。
Breast Cancer Res. 2002;4(4):133-6. doi: 10.1186/bcr436. Epub 2002 May 15.
3
On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.关于他莫昔芬、醋酸甲羟孕酮和氨鲁米特联合激素单一疗法在晚期乳腺癌中的作用
Klin Wochenschr. 1987 Oct 15;65(20):959-66. doi: 10.1007/BF01717830.